Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Rheumatology
Volume 2012, Article ID 923897, 3 pages
http://dx.doi.org/10.1155/2012/923897
Case Report

Efficacy and Safety of Rituximab in the Treatment of Vasculitic Leg Ulcers Associated with Hepatitis C Virus Infection

1Rheumatology Unit, Fundación Valle del Lili, ICESI University, Cali, Colombia
2Internal Medicine Department, Fundación Valle del Lili, ICES University, Cali, Colombia
3Fundación Valle del Lili and Medical School, University of Valle, Cali, Colombia

Received 31 October 2012; Accepted 29 November 2012

Academic Editors: C. Orellana and H. Tennen

Copyright © 2012 Fabio Bonilla-Abadía et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. R. Rosen, “Chronic hepatitis C infection,” The New England Journal of Medicine, vol. 364, no. 25, pp. 2429–2438, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Vassilopoulos and L. H. Calabrese, “Extrahepatic immunological complications of hepatitis C virus infection,” AIDS, vol. 19, supplement 3, pp. S123–S127, 2005. View at Google Scholar · View at Scopus
  3. D. Sène, N. Limal, and P. Cacoub, “Hepatitis C virus-associated extrahepatic manifestations: a review,” Metabolic Brain Disease, vol. 19, no. 3-4, pp. 357–381, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Groves, C. Devereux, and C. McMillan, “A case of cutaneous vasculitis with underlying hepatitis C and cryoglobulinaemia,” Ulster Medical Journal, vol. 77, no. 1, pp. 51–53, 2008. View at Google Scholar · View at Scopus
  5. N. L. Lui, J. Thumboo, and K. Y. Fong, “A case of refractory vasculitic ulcers in a systemic lupus erythematosus patient responding to rituximab and hyperbaric oxygen therapy,” International Journal of Rheumatic Diseases, vol. 12, no. 4, pp. 366–369, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. S. de Vita, L. Quartuccio, M. Isola et al., “A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis,” Arthritis & Rheumatism, vol. 64, pp. 843–853, 2012. View at Google Scholar
  7. B. Terrier, D. Sene, A. Dechartres et al., “Systemic vasculitis in patients with hepatitis C virus infection with and without detectable mixed cryoglobulinemia,” The Journal of Rheumatology, vol. 38, pp. 104–110, 2011. View at Google Scholar
  8. L. Muratori, D. Gibellini, M. Lenzi et al., “Quantification of hepatitis C virus-infected peripheral blood mononuclear cells by in situ reverse transcriptase-polymerase chain reaction,” Blood, vol. 88, no. 7, pp. 2768–2774, 1996. View at Google Scholar · View at Scopus
  9. P. Pileri, Y. Uematsu, S. Campagnoli et al., “Binding of hepatitis C virus to CD81,” Science, vol. 282, no. 5390, pp. 938–941, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Petrarca, L. Rigacci, P. Caini et al., “Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease,” Blood, vol. 116, no. 3, pp. 335–342, 2010. View at Publisher · View at Google Scholar · View at Scopus